Loading...
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
Symonds, R P Davidson, Susan E Chan, S Reed, N S McMahon, T Rai, D Harden, S Paul, J
Symonds, R P
Davidson, Susan E
Chan, S
Reed, N S
McMahon, T
Rai, D
Harden, S
Paul, J
Citations
Altmetric:
Abstract
The aim of the study was to determine the response rate and response duration of cervical cancer previously treated by cisplatin (with or without radiation) to a combination of docetaxel and gemcitabine. Secondary endpoints were assessment of toxicity and quality of life (QoL) of patients receiving the treatment.
Description
Date
2011-10
Publisher
Collections
Keywords
Type
Article
Citation
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. 2011, 123 (1):105-9 Gynecol. Oncol.